Individualized prediction of survival benefits from perioperative chemoradiotherapy for patients with resectable gastric cancer
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Medicine"
DOI: 10.1002/cam4.3350
Abstract: The survival benefits of perioperative chemoradiotherapy (PCRT) and perioperative chemotherapy (PCT) for resectable gastric cancer (GC) patients remain unclear. This study aimed to compare the effects of PCRT and PCT in patients with resectable GC… read more here.
Keywords: gastric cancer; resectable gastric; survival benefits; cancer ... See more keywords
Perioperative chemotherapy for resectable gastric cancer – what is the evidence?
Sign Up to like & getrecommendations! Published in 2017 at "Scandinavian Journal of Gastroenterology"
DOI: 10.1080/00365521.2017.1293727
Abstract: Abstract The UK MAGIC trial published in 2006 was the first RCT to identify improved long-term survival rates using preoperative chemotherapy for resectable gastric or gastroesophageal cancer. Overnight, the treatment regimen impacted European guidelines. However,… read more here.
Keywords: chemotherapy; resectable gastric; survival rates; perioperative chemotherapy ... See more keywords
Economic evaluation of FLOT and ECF/ECX perioperative chemotherapy in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma
Sign Up to like & getrecommendations! Published in 2022 at "BMJ Open"
DOI: 10.1136/bmjopen-2022-060983
Abstract: Objective The perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin plus docetaxel (FLOT) was recommended by the Chinese Society of Clinical Oncology Guidelines for gastric cancer (2018 edition) for patients with resectable gastric or gastro-oesophageal junction adenocarcinoma… read more here.
Keywords: gastric gastro; resectable gastric; ecf ecx; flot ... See more keywords
CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
Sign Up to like & getrecommendations! Published in 2018 at "BMC Cancer"
DOI: 10.1186/s12885-018-4770-2
Abstract: BackgroundAlthough radical surgery remains the cornerstone of cure in resectable gastric cancer, survival remains poor. Current evidence-based (neo)adjuvant strategies have shown to improve outcome, including perioperative chemotherapy, postoperative chemoradiotherapy and postoperative chemotherapy. However, these regimens… read more here.
Keywords: chemotherapy; resectable gastric; chemoradiotherapy; neo adjuvant ... See more keywords
Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14122963
Abstract: Simple Summary Perioperative chemotherapy is the current standard treatment for patients with resectable gastric cancer. Either cisplatin or oxaliplatin could be part of the chemotherapy regimen, of which oxaliplatin is currently most used in the… read more here.
Keywords: resectable gastric; gastric cancer; patients resectable; treatment ... See more keywords
Prognostic Value of the Combination of HB (hemoglobin) and CEA in Resectable Gastric Cancer
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Cancer"
DOI: 10.7150/jca.67600
Abstract: Objective: In order to investigate the prognostic value of a novel biomarker combining serum carcinoembryonic antigen (CEA) and hemoglobin (HB) levels in patients with resectable gastric cancer. Introduction: This retrospective study assessed the relationship between… read more here.
Keywords: resectable gastric; gastric cancer; value; cea ... See more keywords